Tumor response score with neoadjuvant FLOT versus FOLFOX in gastric cancer patients: Results from a United States-based cohort.

James P. De Andrade,Hye Seong Ahn,Joseph Chao,Laleh G. Melstrom,Isaac Benjamin Paz,Yuman Fong,Byrne Lee,Yanghee Woo

Tumor response score with neoadjuvant FLOT versus FOLFOX in gastric cancer patients: Results from a United States-based cohort.

2020

James P. De Andrade
Hye Seong Ahn
Joseph Chao
Laleh G. Melstrom
Isaac Benjamin Paz
Yuman Fong
Byrne Lee
Yanghee Woo

e16573Background: A recent RCT comparing FLOT and ECF regimens for locally advanced gastric cancer found FLOT to be superior in pathologic complete response (PCR) rates: 16% versus 6%. We evaluated...

Keywords:

Oncology
Cancer
FOLFOX
tumor response
Cohort
Internal medicine
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations